Steven D. Ertel, SVP & Chief Business Officer at ACCELERON PHARMA INC (XLRN), sold 2,000 shares at $41.05 ($81K) on 2015-01-15, disclosed to the SEC on 2015-01-16.
Scheduled sale ($81k) by SVP & Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.53 | 1,800 | $73K | 89.9% |
| 2 | $41.05 | 200 | $8K | 10.1% |
| Total | $40.58 avg | 2,000 | $81K | 100% |
| Filing → |
| XLRN | SELL | 2016-04-08 | $1.0M | — | Filing → |
| XLRN | SELL | 2015-09-16 | $67K | — | Filing → |
| XLRN | SELL | 2015-08-19 | $61K | — | Filing → |